37·9 million people are estimated to be living with HIV, and those on successful antiretroviral therapy (ART) can expect to live a normal lifespan. In 2018 global progress towards the UNAIDS 90-90-90 targets (for 90% of those living with HIV to know their status, 90% of these to be on ART, and 90% of these to be virally supressed) stood at 79-78-86. Although much work remains to identify those living with undiagnosed HIV and to roll-out treatment to all, health services must also evolve to incorporate the complex, diverse, and changing health-care needs of people living with HIV. Viral suppression remains an essential goal, but it is not the sole endpoint of HIV care. In recognising the importance of looking at the health and wellbeing of people with HIV we are delighted to introduce a Series, HIV Outcomes Beyond Viral Suppression, published in The Lancet HIV, the first paper of which is included in this issue.

中文翻译：

---

与HIV相处融洽。

据估计，有37·900万人感染了艾滋病毒，并且成功进行抗逆转录病毒疗法（ART）的人可以预期寿命正常。在2018年，实现联合国艾滋病规划署90-90-90目标（90％的艾滋病毒感染者了解自己的状况，其中90％的人接受抗逆转录病毒疗法以及90％的人被病毒抑制）的全球进展为79- 78-86。尽管要确定艾滋病毒携带者并进行全民治疗尚需进行大量工作，但医疗服务也必须不断发展，以纳入艾滋病毒携带者复杂，多样且不断变化的医疗保健需求。抑制病毒仍然是一个基本目标，但这并不是HIV护理的唯一终点。在认识到关注艾滋病病毒感染者的健康和福祉的重要性时，我们很高兴地推出《病毒抑制后的HIV结局》系列，该出版物于《柳叶刀》 HIV，其第一篇论文已包含在本期中。